Marc L Gordon

Marc L. Gordon, M.D., P.C. is a clinical research and medical practice entity led by Dr. Marc L. Gordon, a prominent neurologist specializing in Alzheimer's disease and cognitive disorders. Based in New York, the organization serves as a key clinical trial site for major pharmaceutical and biotechnology companies, participating in Phase 1 through Phase 3 studies for novel neurodegenerative therapies. Dr. Gordon is a recognized expert in the field, frequently serving as a Principal Investigator for landmark trials involving amyloid-targeting and tau-targeting agents such as aducanumab and lecanemab. The practice is affiliated with the Northwell Health system and the Feinstein Institutes for Medical Research, providing advanced diagnostic and management services for patients with memory loss. It plays a vital role in the clinical development pipeline for next-generation neurological treatments by providing high-quality clinical data and patient access.